HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lydia Gedmintas Selected Research

Lydia Gedmintas Research Topics

Disease

5Neoplasms (Cancer)
12/2023 - 01/2018
5Autoimmune Diseases (Autoimmune Disease)
01/2023 - 10/2013
3Rheumatoid Arthritis
12/2023 - 10/2013
3Arthritis (Polyarthritis)
01/2023 - 01/2018
2Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2018 - 03/2014
1Necrosis
01/2023
1Rheumatic Diseases (Rheumatism)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Synovitis
01/2018
1HIV Infections (HIV Infection)
01/2017
1Infections
01/2017
1Giant Cell Arteritis (Horton Disease)
03/2014
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2013
1Systemic Scleroderma (Systemic Sclerosis)
10/2013
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2013
1Osteoporotic Fractures
08/2013
1Femoral Fractures (Femoral Fracture)
08/2013
1Osteoporosis
09/2012
1Metabolic Bone Diseases (Osteopenia)
09/2012
1Purpura
02/2011

Drug/Important Bio-Agent (IBA)

5Immune Checkpoint InhibitorsIBA
12/2023 - 01/2018
2Tumor Necrosis Factor InhibitorsIBA
01/2023 - 01/2017
1Immunologic Factors (Immunomodulators)IBA
12/2023
1Antirheumatic Agents (DMARD)IBA
01/2023
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2023
1Interleukin-6 InhibitorsIBA
01/2023
1Methotrexate (Mexate)FDA LinkGeneric
01/2023
1GlucocorticoidsIBA
01/2022
1LigandsIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1IpilimumabIBA
03/2014
1Silicon Dioxide (Silica)FDA LinkGeneric
10/2013
1Diphosphonates (Bisphosphonates)IBA
08/2013
1Levamisole (Decaris)FDA Link
02/2011

Therapy/Procedure

2Aftercare (After-Treatment)
01/2018 - 03/2014
2Therapeutics
01/2018 - 01/2017
1Immunotherapy
01/2018
1Art Therapy
09/2012